David Stevens

David Stevens has over 20 years of work experience in various leadership roles in the pharmaceutical industry. David is currently serving as the Global Chief Commercial Officer (CCO) at Kindeva Drug Delivery. Prior to this, they held the position of Chief Executive Officer (CEO) at Arranta Bio. David also served as the President & Chief Operating Officer (COO) and the Chief Operating Officer (COO) at Arranta Bio.

Before joining Arranta Bio, David Stevens worked at AMRI (Albany Molecular Research Inc.) as the Senior Vice President & Head of Drug Product and the Vice President, Sales & Marketing. David also held the position of Senior Director, Site Head, where they were responsible for site leadership and management of a sterile dosage form development and production business.

Earlier in their career, David Stevens worked at Aptuit, where they held multiple roles including Senior Director, Site Head, Director, Strategic Pricing & Business Operations, Director, Operational Excellence & Planning, Senior Manager, Black Belt, Black Belt, and Business Analyst, Sales & Marketing. In these roles, they gained experience in P&L management, strategic planning, operational excellence, and sales operations.

David Stevens started their career at Charles River Laboratories and Inveresk, where they worked in commercial development and as a commercial officer, respectively.

Overall, David Stevens has demonstrated strong leadership skills and a track record of driving transformative change and business growth in the pharmaceutical industry.

David Stevens received their MBA degree with a focus in Strategy, Finance, and Marketing from The University of Edinburgh. David attended the university from 2007 to 2010. In addition to their MBA, they also obtained a Lean Six Sigma Black Belt Certification from the International Society of Six Sigma Professionals in December 2009.